Association of tumor growth rate with overall survival and recurrence among patients with laryngeal squamous cell carcinoma.

Faye G ZhangShankar ViswanathanChenxin ZhangRichard V SmithBradley A SchiffThomas J Ow Madhur K GargRafi KabarritiVikas Mehta

Published in: Head & neck (2024)

TGR >0.036 mL/day during TTI was associated with decreased OS, and >0.082 mL/day was associated with increased recurrence. Tumor measurement in patients experiencing delay may identify those who could benefit from escalated therapy.

Keyphrases

squamous cell carcinoma
end stage renal disease
free survival
newly diagnosed
ejection fraction
chronic kidney disease
stem cells
radiation therapy
patient reported outcomes
lymph node metastasis
mesenchymal stem cells
bone marrow
cell therapy